DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.34, $0.11 better than the analyst estimate of $0.23. Revenue for the quarter came in at $871.3 million versus the consensus estimate of $841.18 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.